APIChangelogInfo
Common stock only
S&P 500 only
Director Only
10% Owner Only

Trans Codes

Select...
Amount
-
Stock
Insider transactions
AURA BIOSCIENCES
tastytradeTrade AURA
AURA Insider Trades:
all
Created with Highcharts 10.1.0►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►PriceVolumeJan '22May '22Sep '22Jan '23May '23Sep '23Jan '24May '24Sep '24Jan '25May '250510152025300500k1 000k1 500k2 000k2 500k3 000k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-05-16
2025-05-20
GIBNEY ANTHONY
Chief Financial and Business O...
P - Purchase
Common Stock Warrants (right to buy)
12,500
1
$301.61M
2025-05-16
2025-05-20
GIBNEY ANTHONY
Chief Financial and Business O...
P - Purchase
Common Stock
50,000
$5.00
250K
1
$301.61M
2025-05-16
2025-05-20
JOHNSON DAVID MICHAEL
P - Purchase
Common Stock Warrants (right to buy)
5,000
1
$301.61M
2025-05-16
2025-05-20
JOHNSON DAVID MICHAEL
P - Purchase
Common Stock
20,000
$5.00
100K
1
$301.61M
2025-05-16
2025-05-20
GIBNEY ANTHONY
Chief Financial and Business O...
S - Sale
Common Stock
-1,519
$5.00
-7,595
1
$301.61M
2025-04-16
2025-04-16
ELAZZOUZI AMY
Senior Vice President, Finance
S - Sale
Common Stock
-897
$5.00
-4,485
1
$301.61M
2025-04-16
2025-04-16
KILROY CONOR
Chief Legal Officer and Secret...
S - Sale
Common Stock
-7,162
$5.00
-35,810
1
$301.61M
2025-04-16
2025-04-16
ELAZZOUZI AMY
Senior Vice President, Finance
S - Sale
Common Stock
-897
$5.00
-4,485
1
$301.61M
2025-04-16
2025-04-16
KILROY CONOR
Chief Legal Officer and Secret...
S - Sale
Common Stock
-7,162
$5.00
-35,810
1
$301.61M
2025-03-31
2025-04-02
BITETTI TERESA MARIE
A - Grant
Stock Option (Right to Buy)
29,000
$0.00
1
$301.61M
2025-03-31
2025-04-02
BITETTI TERESA MARIE
A - Grant
Common Stock
21,000
$0.00
1
$301.61M
2025-02-18
2025-02-18
DE LOS PINOS ELISABET
President and Chief Executive ...
S - Sale
Common Stock
-20,221
$8.00
-162K
1
$301.61M
2025-02-18
2025-02-18
ELAZZOUZI AMY
Senior Vice President, Finance
S - Sale
Common Stock
-1,404
$8.00
-11,232
1
$301.61M
2025-02-18
2025-02-18
HOPKINS JANET JILL
Chief Medical Officer
S - Sale
Common Stock
-2,534
$8.00
-20,272
1
$301.61M
2025-02-18
2025-02-18
PLAVSIC MARK
Chief Technology Officer
S - Sale
Common Stock
-2,151
$8.00
-17,208
1
$301.61M
2025-02-18
2025-02-18
DE LOS PINOS ELISABET
President and Chief Executive ...
S - Sale
Common Stock
-20,221
$8.00
-162K
1
$301.61M
2025-02-18
2025-02-18
ELAZZOUZI AMY
Senior Vice President, Finance
S - Sale
Common Stock
-1,404
$8.00
-11,232
1
$301.61M
2025-02-18
2025-02-18
HOPKINS JANET JILL
Chief Medical Officer
S - Sale
Common Stock
-2,534
$8.00
-20,272
1
$301.61M
2025-02-18
2025-02-18
PLAVSIC MARK
Chief Technology Officer
S - Sale
Common Stock
-2,151
$8.00
-17,208
1
$301.61M
2025-02-18
2025-02-18
DE LOS PINOS ELISABET
President and Chief Executive ...
S - Sale
Common Stock
-20,221
$8.00
-162K
1
$301.61M
2025-02-18
2025-02-18
ELAZZOUZI AMY
Senior Vice President, Finance
S - Sale
Common Stock
-1,404
$8.00
-11,232
1
$301.61M
2025-02-18
2025-02-18
HOPKINS JANET JILL
Chief Medical Officer
S - Sale
Common Stock
-2,534
$8.00
-20,272
1
$301.61M
2025-02-18
2025-02-18
PLAVSIC MARK
Chief Technology Officer
S - Sale
Common Stock
-2,151
$8.00
-17,208
1
$301.61M
2025-02-03
2025-02-04
DE LOS PINOS ELISABET
President and Chief Executive ...
A - Grant
Stock Option (Right to Buy)
256K
$0.00
1
$301.61M
2025-02-03
2025-02-04
DE LOS PINOS ELISABET
President and Chief Executive ...
A - Grant
Common Stock
194K
$0.00
1
$301.61M
2025-02-03
2025-02-04
ELAZZOUZI AMY
Senior Vice President, Finance
A - Grant
Stock Option (Right to Buy)
29,760
$0.00
1
$301.61M
2025-02-03
2025-02-04
ELAZZOUZI AMY
Senior Vice President, Finance
A - Grant
Common Stock
45,240
$0.00
1
$301.61M
2025-02-03
2025-02-04
HOPKINS JANET JILL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
79,365
$0.00
1
$301.61M
2025-02-03
2025-02-04
HOPKINS JANET JILL
Chief Medical Officer
A - Grant
Common Stock
121K
$0.00
1
$301.61M
2025-02-03
2025-02-04
KILROY CONOR
Chief Legal Officer and Secret...
A - Grant
Stock Option (Right to Buy)
59,525
$0.00
1
$301.61M
2025-02-03
2025-02-04
KILROY CONOR
Chief Legal Officer and Secret...
A - Grant
Common Stock
90,475
$0.00
1
$301.61M
2025-02-03
2025-02-04
PLAVSIC MARK
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
59,525
$0.00
1
$301.61M
2025-02-03
2025-02-04
PLAVSIC MARK
Chief Technology Officer
A - Grant
Common Stock
90,475
$0.00
1
$301.61M
2025-02-03
2025-02-04
DE LOS PINOS ELISABET
President and Chief Executive ...
A - Grant
Stock Option (Right to Buy)
256K
$0.00
1
$301.61M
2025-02-03
2025-02-04
DE LOS PINOS ELISABET
President and Chief Executive ...
A - Grant
Common Stock
194K
$0.00
1
$301.61M
2025-02-03
2025-02-04
ELAZZOUZI AMY
Senior Vice President, Finance
A - Grant
Stock Option (Right to Buy)
29,760
$0.00
1
$301.61M
2025-02-03
2025-02-04
ELAZZOUZI AMY
Senior Vice President, Finance
A - Grant
Common Stock
45,240
$0.00
1
$301.61M
2025-02-03
2025-02-04
HOPKINS JANET JILL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
79,365
$0.00
1
$301.61M
2025-02-03
2025-02-04
HOPKINS JANET JILL
Chief Medical Officer
A - Grant
Common Stock
121K
$0.00
1
$301.61M
2025-02-03
2025-02-04
KILROY CONOR
Chief Legal Officer and Secret...
A - Grant
Stock Option (Right to Buy)
59,525
$0.00
1
$301.61M
2025-02-03
2025-02-04
KILROY CONOR
Chief Legal Officer and Secret...
A - Grant
Common Stock
90,475
$0.00
1
$301.61M
2025-02-03
2025-02-04
PLAVSIC MARK
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
59,525
$0.00
1
$301.61M
2025-02-03
2025-02-04
PLAVSIC MARK
Chief Technology Officer
A - Grant
Common Stock
90,475
$0.00
1
$301.61M
2025-01-21
2025-01-21
DE LOS PINOS ELISABET
President and Chief Executive ...
S - Sale
Common Stock
-15,955
$8.00
-128K
1
$301.61M
2025-01-21
2025-01-21
ELAZZOUZI AMY
Vice President, Finance
S - Sale
Common Stock
-1,001
$8.00
-8,008
1
$301.61M
2024-11-18
2024-11-18
HOPKINS JANET JILL
Chief Medical Officer
S - Sale
Common Stock
-11,822
$9.00
-106K
1
$301.61M
2024-10-29
2024-10-29
AMY ELAZZOUZI
S - Sale
-553
$11.00
-6,083
1
$301.61M
2024-10-29
2024-10-29
DE LOS PINOS ELISABET
President and Chief Executive ...
S - Sale
Common Stock
-9,200
$11.00
-101K
1
$301.61M
2024-10-29
2024-10-29
ELAZZOUZI AMY
Vice President, Finance
S - Sale
Common Stock
-553
$11.00
-6,083
1
$301.61M
2024-10-29
2024-10-29
FEDER JULIE
Chief Financial Officer
S - Sale
-3,249
$11.00
-35,739
1
$301.61M
2024-10-18
2024-10-21
FEDER JULIE
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-25,131
$0.00
3
$301.61M
2024-10-18
2024-10-21
FEDER JULIE
Chief Financial Officer
M - Exercise
Common Stock
25,131
$3.00
75,393
3
$301.61M
2024-10-18
2024-10-21
FEDER JULIE
Chief Financial Officer
S - Sale
Common Stock
-25,131
$12.00
-302K
1
$301.61M
2024-10-18
2024-10-18
DE LOS PINOS ELISABET
President and Chief Executive ...
M - Exercise
Stock Option (Right to Buy)
-24,992
$0.00
1
$301.61M
2024-10-18
2024-10-18
DE LOS PINOS ELISABET
President and Chief Executive ...
M - Exercise
Common Stock
24,992
$3.00
74,976
1
$301.61M
2024-10-18
2024-10-18
DE LOS PINOS ELISABET
President and Chief Executive ...
S - Sale
Common Stock
-24,992
$12.00
-300K
1
$301.61M
2024-10-16
2024-10-16
PLAVSIC MARK
Chief Technology Officer
S - Sale
Common Stock
-7,383
$10.00
-73,830
1
$301.61M
2024-09-27
2024-10-01
DE LOS PINOS ELISABET
President and Chief Executive ...
M - Exercise
Stock Option (Right to Buy)
-5,474
$0.00
1
$301.61M
2024-09-27
2024-10-01
DE LOS PINOS ELISABET
President and Chief Executive ...
M - Exercise
Common Stock
5,474
$6.00
32,844
1
$301.61M
2024-06-20
2024-06-24
JOHNSON DAVID MICHAEL
A - Grant
Stock Option (Right to Buy)
14,500
$0.00
1
$301.61M
2024-06-20
2024-06-24
JOHNSON DAVID MICHAEL
A - Grant
Common Stock
10,500
$0.00
1
$301.61M
2024-06-20
2024-06-24
MATTESSICH ANTONY
A - Grant
Stock Option (Right to Buy)
14,500
$0.00
1
$301.61M
2024-06-20
2024-06-24
MATTESSICH ANTONY
A - Grant
Common Stock
10,500
$0.00
1
$301.61M
2024-06-20
2024-06-24
SRIVASTAVA SAPNA
A - Grant
Stock Option (Right to Buy)
14,500
$0.00
1
$301.61M
2024-06-20
2024-06-24
SRIVASTAVA SAPNA
A - Grant
Common Stock
10,500
$0.00
1
$301.61M
2024-04-02
2024-04-04
KILROY CONOR
General Counsel and Secretary
A - Grant
Stock Option (Right to Buy)
144K
$0.00
1
$301.61M
2024-04-02
2024-04-04
KILROY CONOR
General Counsel and Secretary
A - Grant
Common Stock
96,000
$0.00
1
$301.61M
2024-03-04
2024-03-04
CADMUS RICH SHANTEL RICH
S - Sale
-20,000
$9.00
-180K
1
$301.61M
2024-02-23
2024-02-23
CADMUS RICH SHANTEL RICH
S - Sale
-15,974
$9.00
-144K
1
$301.61M
2024-02-01
2024-02-02
DE LOS PINOS ELISABET
President and Chief Executive ...
A - Grant
Stock Option (Right to Buy)
237K
$0.00
1
$301.61M
2024-02-01
2024-02-02
DE LOS PINOS ELISABET
President and Chief Executive ...
A - Grant
Common Stock
163K
$0.00
1
$301.61M
2024-02-01
2024-02-02
FEDER JULIE
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
104K
$0.00
1
$301.61M
2024-02-01
2024-02-02
FEDER JULIE
Chief Financial Officer
A - Grant
Common Stock
71,285
$0.00
1
$301.61M
2024-02-01
2024-02-02
HOPKINS JANET JILL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
41,485
$0.00
1
$301.61M
2024-02-01
2024-02-02
HOPKINS JANET JILL
Chief Medical Officer
A - Grant
Common Stock
28,515
$0.00
1
$301.61M
2024-01-23
2024-01-24
DE LOS PINOS ELISABET
President and Chief Executive ...
S - Sale
Common Stock
-15,853
$8.00
-127K
1
$301.61M
2024-01-23
2024-01-24
FEDER JULIE
Chief Financial Officer
S - Sale
Common Stock
-6,609
$8.00
-52,872
1
$301.61M
2024-01-08
2024-01-08
CADMUS RICH SHANTEL RICH JT TEN
S - Sale
-10,000
$9.00
-90,000
1
$301.61M
2024-01-02
2024-01-02
CADMUS RICH SHANTEL RICH JT TEN
S - Sale
-9,748
$9.00
-87,732
1
$301.61M
2023-12-15
2023-12-15
CADMUS RICH &SHANTEL RICH JT TEN
S - Sale
-90,039
$9.00
-810K
1
$301.61M
2023-11-09
2023-11-09
MATRIX CAPITAL MANAGEMENT COMPANY, LP
P - Purchase
Common Stock, par value $0.00001 per share (Common Stock)
1.56M
$9.00
14M
1
$301.61M
2023-11-08
2023-11-09
JOHNSON DAVID MICHAEL
P - Purchase
Common Stock
29,601
$7.00
207K
3
$301.61M
2023-11-07
2023-11-09
JOHNSON DAVID MICHAEL
P - Purchase
Common Stock
170K
$7.00
1.19M
3
$301.61M
2023-11-06
2023-11-07
FEDER JULIE
Chief Financial Officer
S - Sale
Common Stock
-3,900
$12.00
-46,800
1
$301.61M
2023-11-06
2023-11-07
DE LOS PINOS ELISABET
President and Chief Executive ...
S - Sale
Common Stock
-7,449
$12.00
-89,388
1
$301.61M
2023-11-06
2023-11-07
DE LOS PINOS ELISABET
President and Chief Executive ...
M - Exercise
Stock Option (Right to Buy)
-3,800
$0.00
1
$301.61M
2023-11-06
2023-11-07
DE LOS PINOS ELISABET
President and Chief Executive ...
M - Exercise
Common Stock
3,800
$3.00
11,400
1
$301.61M
2023-11-06
2023-11-07
FEDER JULIE
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-3,900
$0.00
1
$301.61M
2023-11-06
2023-11-07
FEDER JULIE
Chief Financial Officer
M - Exercise
Common Stock
3,900
$3.00
11,700
1
$301.61M
2023-11-06
2023-11-06
DE LOS PINOS ELISABET
President and Chief Executive ...
S - Sale
-30,149
$12.00
-362K
1
$301.61M
2023-11-06
2023-11-06
FEDER JULIE
Chief Financial Officer
S - Sale
-17,500
$12.00
-210K
1
$301.61M
2023-11-01
2023-11-03
HOPKINS JANET JILL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$301.61M
2023-11-01
2023-11-03
HOPKINS JANET JILL
Chief Medical Officer
A - Grant
Common Stock
135K
$0.00
1
$301.61M
2023-10-30
2023-11-03
RICH CADMUS
Chief Medical Officer, Head of...
S - Sale
-1,706
$7.00
-11,942
1
$301.61M
2023-10-30
2023-11-01
FEDER JULIE
Chief Financial Officer
S - Sale
Common Stock
-3,385
$7.00
-23,695
1
$301.61M
2023-10-30
2023-11-01
DE LOS PINOS ELISABET
President and Chief Executive ...
S - Sale
Common Stock
-9,586
$7.00
-67,102
1
$301.61M
2023-10-04
2023-10-05
JOHNSON DAVID MICHAEL
P - Purchase
Common Stock
6,566
$9.00
59,094
1
$301.61M
2023-10-03
2023-10-05
JOHNSON DAVID MICHAEL
P - Purchase
Common Stock
13,500
$8.00
108K
1
$301.61M
2023-06-07
2023-06-09
PAREKH RAJESH
A - Grant
Stock Option (Right to Buy)
16,000
$0.00
1
$301.61M
2023-06-07
2023-06-09
MATTESSICH ANTONY
A - Grant
Stock Option (Right to Buy)
16,000
$0.00
1
$301.61M
2023-06-07
2023-06-09
SRIVASTAVA SAPNA
A - Grant
Stock Option (Right to Buy)
16,000
$0.00
1
$301.61M
2023-06-07
2023-06-09
JOHNSON DAVID MICHAEL
A - Grant
Stock Option (Right to Buy)
16,000
$0.00
1
$301.61M
2023-06-07
2023-06-07
DE ROSCH MARK
Chief Operating Officer
S - Sale
-77,238
$13.00
-1.00M
1
$301.61M
2023-06-02
2023-06-02
DE ROSCH MARK
Chief Operating Officer
S - Sale
-65,000
$12.00
-780K
1
$301.61M
2023-01-19
2023-01-23
RICH CADMUS
Chief Medical Officer, Head of...
A - Grant
Common Stock
34,125
$0.00
1
$301.61M
2023-01-19
2023-01-23
DE ROSCH MARK
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
65,000
1
$301.61M
2023-01-19
2023-01-23
DE LOS PINOS ELISABET
President and Chief Executive ...
A - Grant
Stock Option (Right to Buy)
188K
1
$301.61M
2023-01-19
2023-01-23
DE LOS PINOS ELISABET
President and Chief Executive ...
A - Grant
Common Stock
122K
$0.00
1
$301.61M
2023-01-19
2023-01-23
DE ROSCH MARK
Chief Operating Officer
A - Grant
Common Stock
42,250
$0.00
1
$301.61M
2023-01-19
2023-01-23
FEDER JULIE
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
75,000
1
$301.61M
2023-01-19
2023-01-23
FEDER JULIE
Chief Financial Officer
A - Grant
Common Stock
48,750
$0.00
1
$301.61M
2023-01-19
2023-01-23
RICH CADMUS
Chief Medical Officer, Head of...
A - Grant
Stock Option (Right to Buy)
52,500
1
$301.61M
2023-01-06
2023-01-09
JOHNSON DAVID MICHAEL
P - Purchase
Common Stock
1,604
$11.00
17,644
2
$301.61M
2023-01-05
2023-01-09
JOHNSON DAVID MICHAEL
P - Purchase
Common Stock
396
$10.00
3,960
2
$301.61M
2022-12-28
2022-12-30
JOHNSON DAVID MICHAEL
P - Purchase
Common Stock
4,000
$10.00
40,000
2
$301.61M
2022-12-01
2022-12-15
JOHNSON DAVID MICHAEL
P - Purchase
Common Stock
10,000
$12.00
120K
2
$301.61M
2022-12-05
2022-12-07
MATRIX CAPITAL MANAGEMENT COMPANY, LP
P - Purchase
Common Stock, par value $0.00001 per share ("Common Stock")
1.25M
$12.00
15M
1
$301.61M
2022-10-31
2022-11-02
DE LOS PINOS ELISABET
President and Chief Executive ...
S - Sale
Common Stock
-5,706
$12.00
-68,472
1
$301.61M
2022-10-31
2022-11-02
DE ROSCH MARK
Chief Operating Officer
S - Sale
Common Stock
-1,115
$12.00
-13,380
1
$301.61M
2022-10-31
2022-11-02
FEDER JULIE
Chief Financial Officer
S - Sale
Common Stock
-2,015
$12.00
-24,180
1
$301.61M
2022-10-31
2022-11-02
RICH CADMUS
Chief Medical Officer, Head of...
S - Sale
Common Stock
-1,672
$12.00
-20,064
1
$301.61M
2022-06-15
2022-06-17
JOHNSON DAVID MICHAEL
A - Grant
Stock Option (Right to Buy)
16,000
$0.00
1
$301.61M
2022-06-15
2022-06-17
MATTESSICH ANTONY
A - Grant
Stock Option (Right to Buy)
16,000
$0.00
1
$301.61M
2022-06-15
2022-06-17
PAREKH RAJESH
A - Grant
Stock Option (Right to Buy)
16,000
$0.00
1
$301.61M
2022-06-15
2022-06-17
SRIVASTAVA SAPNA
A - Grant
Stock Option (Right to Buy)
16,000
$0.00
1
$301.61M
2022-06-13
2022-06-14
JOHNSON DAVID MICHAEL
P - Purchase
Common Stock
34,000
$14.00
476K
3
$301.61M
2022-06-10
2022-06-14
JOHNSON DAVID MICHAEL
P - Purchase
Common Stock
16,000
$15.00
240K
3
$301.61M
2021-11-02
2021-11-04
MATRIX CAPITAL MANAGEMENT COMPANY, LP
C - Conversion
Series E Convertible Preferred Stock
-2.33M
$0.00
1
$301.61M
2021-11-02
2021-11-04
MATRIX CAPITAL MANAGEMENT COMPANY, LP
C - Conversion
Common Stock, par value $0.00001 per share ("Common Stock")
2.33M
1
$301.61M
2021-11-02
2021-11-04
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD
C - Conversion
Series D-1 Convertible Preferred Stock
-1.69M
$0.00
2
$301.61M
2021-11-02
2021-11-04
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD
C - Conversion
Series D-2 Convertible Preferred Stock
-382K
$0.00
2
$301.61M
2021-11-02
2021-11-04
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD
C - Conversion
Series E Convertible Preferred Stock
-258K
$0.00
2
$301.61M
2021-11-02
2021-11-04
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD
C - Conversion
Common Stock
2.33M
2
$301.61M
2021-11-02
2021-11-04
MATRIX CAPITAL MANAGEMENT COMPANY, LP
P - Purchase
Common Stock
1.78M
$14.00
25M
1
$301.61M
2021-11-02
2021-11-04
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD
P - Purchase
Common Stock
710K
$14.00
9.94M
2
$301.61M
2021-11-02
2021-11-02
DE LOS PINOS ELISABET
President and Chief Executive ...
C - Conversion
Series A-1 Preferred Stock
-3,042
1
$301.61M
2021-11-02
2021-11-02
DE LOS PINOS ELISABET
President and Chief Executive ...
C - Conversion
Series A-2 Preferred Stock
-1,510
1
$301.61M
2021-11-02
2021-11-02
DE LOS PINOS ELISABET
President and Chief Executive ...
C - Conversion
Common Stock
4,552
$0.00
1
$301.61M
2021-11-02
2021-11-02
JOHNSON DAVID MICHAEL
C - Conversion
Series E Convertible Preferred Stock
-140K
1
$301.61M
2021-11-02
2021-11-02
JOHNSON DAVID MICHAEL
C - Conversion
Common Stock
140K
$0.00
1
$301.61M
2021-10-28
2021-10-29
DE LOS PINOS ELISABET
President and Chief Executive ...
A - Grant
Stock Option (Right to Buy)
319K
1
$301.61M
2021-10-28
2021-10-29
DE LOS PINOS ELISABET
President and Chief Executive ...
A - Grant
Common Stock
74,357
$0.00
1
$301.61M
2021-10-28
2021-10-29
DE ROSCH MARK
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
75,000
1
$301.61M
2021-10-28
2021-10-29
DE ROSCH MARK
Chief Operating Officer
A - Grant
Common Stock
17,500
$0.00
1
$301.61M
2021-10-28
2021-10-29
FEDER JULIE
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
113K
1
$301.61M
2021-10-28
2021-10-29
FEDER JULIE
Chief Financial Officer
A - Grant
Common Stock
26,250
$0.00
1
$301.61M
2021-10-28
2021-10-29
JOHNSON DAVID MICHAEL
A - Grant
Stock Option (Right to Buy)
24,000
$0.00
1
$301.61M
2021-10-28
2021-10-29
MATTESSICH ANTONY
A - Grant
Stock Option (Right to Buy)
16,000
$0.00
1
$301.61M
2021-10-28
2021-10-29
PAREKH RAJESH
A - Grant
Stock Option (Right to Buy)
16,000
$0.00
1
$301.61M
2021-10-28
2021-10-29
PRIMIANO CHRISTOPHER BRETT
Chief Business Officer
A - Grant
Stock Option (Right to Buy)
37,500
1
$301.61M
2021-10-28
2021-10-29
PRIMIANO CHRISTOPHER BRETT
Chief Business Officer
A - Grant
Common Stock
8,750
$0.00
1
$301.61M
2021-10-28
2021-10-29
RICH CADMUS
Chief Medical Officer Head of ...
A - Grant
Stock Option (Right to Buy)
113K
1
$301.61M
2021-10-28
2021-10-29
RICH CADMUS
Chief Medical Officer Head of ...
A - Grant
Common Stock
26,250
$0.00
1
$301.61M
2021-10-28
2021-10-29
SRIVASTAVA SAPNA
A - Grant
Stock Option (Right to Buy)
16,000
$0.00
1
$301.61M